Literature DB >> 1774404

Abrupt hemodynamic improvement in late septic shock with physiological doses of glucocorticoids.

A J Schneider, H J Voerman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1774404     DOI: 10.1007/bf01720688

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  5 in total

1.  Cortisol response to corticotropin and survival in septic shock.

Authors:  P M Rothwell; Z F Udwadia; P G Lawler
Journal:  Lancet       Date:  1991-03-09       Impact factor: 79.321

2.  Variations in adrenocortical responsiveness during severe bacterial infections. Unrecognized adrenocortical insufficiency in severe bacterial infections.

Authors:  W J Sibbald; A Short; M P Cohen; R F Wilson
Journal:  Ann Surg       Date:  1977-07       Impact factor: 12.969

3.  Serum cortisol levels in severely stressed patients.

Authors:  W E Finlay; J I McKee
Journal:  Lancet       Date:  1982-06-19       Impact factor: 79.321

4.  A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock.

Authors:  R C Bone; C J Fisher; T P Clemmer; G J Slotman; C A Metz; R A Balk
Journal:  N Engl J Med       Date:  1987-09-10       Impact factor: 91.245

5.  Hemodynamic determinants of mortality in human septic shock.

Authors:  A B Groeneveld; W Bronsveld; L G Thijs
Journal:  Surgery       Date:  1986-02       Impact factor: 3.982

  5 in total
  11 in total

Review 1.  New evidence for old therapies in catecholamine-dependent septic shock.

Authors:  J O Friedrich; S E Lapinsky
Journal:  Intensive Care Med       Date:  2001-04       Impact factor: 17.440

2.  Haemodynamic improvement in refractory septic shock with cortisol replacement therapy.

Authors:  J Briegel; H Forst; W Kellermann; M Haller; K Peter
Journal:  Intensive Care Med       Date:  1992       Impact factor: 17.440

3.  A comparison of the adrenocortical response during septic shock and after complete recovery.

Authors:  J Briegel; G Schelling; M Haller; W Mraz; H Forst; K Peter
Journal:  Intensive Care Med       Date:  1996-09       Impact factor: 17.440

4.  Guidelines for the diagnosis and management of critical illness-related corticosteroid insufficiency (CIRCI) in critically ill patients (Part I): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017.

Authors:  Djillali Annane; Stephen M Pastores; Bram Rochwerg; Wiebke Arlt; Robert A Balk; Albertus Beishuizen; Josef Briegel; Joseph Carcillo; Mirjam Christ-Crain; Mark S Cooper; Paul E Marik; Gianfranco Umberto Meduri; Keith M Olsen; Sophia Rodgers; James A Russell; Greet Van den Berghe
Journal:  Intensive Care Med       Date:  2017-09-21       Impact factor: 17.440

Review 5.  Sepsis and septic shock. II. Treatment.

Authors:  J Mayer; R Hajek; J Vorlicek; M Tomiska
Journal:  Support Care Cancer       Date:  1995-03       Impact factor: 3.603

Review 6.  Update on adrenal insufficiency in patients with liver cirrhosis.

Authors:  Anca Trifan; Stefan Chiriac; Carol Stanciu
Journal:  World J Gastroenterol       Date:  2013-01-28       Impact factor: 5.742

Review 7.  The hypothalamic-pituitary-adrenal axis in critical illness.

Authors:  Shekhar Venkataraman; Ricardo Munoz; Cristina Candido; Selma Feldman Witchel
Journal:  Rev Endocr Metab Disord       Date:  2007-12       Impact factor: 6.514

8.  The Treatment of Severe Group A Streptococcal Infections.

Authors:  Anna Norrby-Teglund; S. Ragnar Norrby; Donald E. Low
Journal:  Curr Infect Dis Rep       Date:  2003-02       Impact factor: 3.725

9.  Adrenocortical function during septic shock.

Authors:  G Bouachour; P Tirot; J P Gouello; E Mathieu; J F Vincent; P Alquier
Journal:  Intensive Care Med       Date:  1995-01       Impact factor: 17.440

10.  Low-dose hydrocortisone infusion attenuates the systemic inflammatory response syndrome. The Phospholipase A2 Study Group.

Authors:  J Briegel; W Kellermann; H Forst; M Haller; M Bittl; G E Hoffmann; M Büchler; W Uhl; K Peter
Journal:  Clin Investig       Date:  1994-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.